Sign in
4

Changes in Ownership

aTYR PHARMA INC Filed Acc 0001209191-16-090192

Options or other derivatives

  • CEO and Director acquired 148,732 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
MENDLEIN JOHN CEO and Director 2016-01-04 Grant or award · Employee Stock Option (right to buy) +148,732 148,732 D
Loading xslF345X03/doc4.xml…